bupranolol has been researched along with Glaucoma in 18 studies
Bupranolol: An adrenergic-beta-2 antagonist that has been used for cardiac arrhythmia, angina pectoris, hypertension, glaucoma, and as an antithrombotic.
Glaucoma: An ocular disease, occurring in many forms, having as its primary characteristics an unstable or a sustained increase in the intraocular pressure which the eye cannot withstand without damage to its structure or impairment of its function. The consequences of the increased pressure may be manifested in a variety of symptoms, depending upon type and severity, such as excavation of the optic disk, hardness of the eyeball, corneal anesthesia, reduced visual acuity, seeing of colored halos around lights, disturbed dark adaptation, visual field defects, and headaches. (Dictionary of Visual Science, 4th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "In this study we examined the effect of Bupranolol eye drops on 10 patients with open-angle glaucoma." | 7.66 | [Long-term treatment of open-angle glaucoma with bupranolol eye drops (author's transl)]. ( Demmler, N, 1980) |
| "In this study we report on the effect of Bupranolol eye drops on 10 patients who, prior to treatment, experienced decompensation of their glaucoma in spite of the use of miotics or who were not given biotics treatment because of their occupation or because of severe subjective complaints." | 7.66 | [Long-term treatment of angle-closure glaucoma with bupranolol eye drops (author's transl)]. ( Demmler, N, 1980) |
| "2% solutions of bupranolol on intraocular pressure were investigated in 21 and respectively 20 eyes with chronic uncomplicated open-angle glaucoma." | 7.66 | [Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)]. ( Oancea, I; Trif, V, 1979) |
| "Topically applied bupranolol, a beta-adrenergic blocking agent, has been shown to have a marked effectiveness in lowering the intraocular pressure of the normal and glaucomatous eyes." | 7.66 | Effects of topically applied bupranolol on the intraocular pressure. Effects on the untreated eye. ( Ohba, N; Sakimoto, G; Une, H, 1979) |
| "In this study we examined the effect of Bupranolol eye drops on 10 patients with open-angle glaucoma." | 3.66 | [Long-term treatment of open-angle glaucoma with bupranolol eye drops (author's transl)]. ( Demmler, N, 1980) |
| "2% solutions of bupranolol on intraocular pressure were investigated in 21 and respectively 20 eyes with chronic uncomplicated open-angle glaucoma." | 3.66 | [Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)]. ( Oancea, I; Trif, V, 1979) |
| "Topically applied bupranolol, a beta-adrenergic blocking agent, has been shown to have a marked effectiveness in lowering the intraocular pressure of the normal and glaucomatous eyes." | 3.66 | Effects of topically applied bupranolol on the intraocular pressure. Effects on the untreated eye. ( Ohba, N; Sakimoto, G; Une, H, 1979) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Demmler, N | 3 |
| Ogino, T | 1 |
| Masuda, S | 1 |
| Shiokawa, K | 1 |
| Yoshikawa, T | 1 |
| Sato, T | 1 |
| Miki, H | 2 |
| Moriyama, R | 1 |
| Itagaki, Y | 1 |
| Takahashi, N | 1 |
| Oancea, I | 5 |
| Krieglstein, GK | 2 |
| Leydhecker, W | 1 |
| Stiegler, G | 1 |
| Trif, V | 4 |
| Călugăru, M | 1 |
| Fujinaga, Y | 1 |
| Yamanishi, Y | 1 |
| Setogawa, T | 1 |
| Totsuka, H | 1 |
| Matsuo, T | 1 |
| Araie, M | 1 |
| Takase, M | 1 |
| Sakimoto, G | 1 |
| Une, H | 1 |
| Ohba, N | 1 |
3 trials available for bupranolol and Glaucoma
| Article | Year |
|---|---|
[Drug tolerance of glaucomatous eyes to beta-receptor blockers].
Topics: Adult; Bupranolol; Clinical Trials as Topic; Drug Tolerance; Female; Glaucoma; Humans; Intraocular P | 1978 |
The intraocular pressure responses of low-dose bupranolol (Ophtorenin) and methazolamide (Neptazane) in glaucomatous eyes. A controlled clinical study.
Topics: Bupranolol; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Glaucoma; Huma | 1979 |
[Pressure reducing effect of bupranolol and pilo eserine in chronic glaucoma with open iridocorneal angle].
Topics: Adult; Aged; Bupranolol; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Pilocarp | 1979 |
15 other studies available for bupranolol and Glaucoma
| Article | Year |
|---|---|
[Treatment of glaucoma with beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Binding, Competitive; Bupranolol; Drug Interactions; Glaucoma; Humans; | 1980 |
[Studies on experimental steroid glaucoma. Report 6. The relation between intraocular pressure and aqueous levels of cAMP in steroid-treated young rabbits' eyes (author's transl)].
Topics: Animals; Aqueous Humor; Bucladesine; Bupranolol; Cyclic AMP; Glaucoma; Intraocular Pressure; Rabbits | 1980 |
[Longterm bupranolol therapy in glaucoma eyes: a one to two year follow up study (author's transl)].
Topics: Adult; Aged; Bupranolol; Female; Follow-Up Studies; Glaucoma; Humans; Male; Middle Aged; Ophthalmic | 1982 |
[Long-term treatment of open-angle glaucoma with bupranolol eye drops (author's transl)].
Topics: Adult; Aged; Bupranolol; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; | 1980 |
[Long-term treatment of angle-closure glaucoma with bupranolol eye drops (author's transl)].
Topics: Adult; Aged; Bupranolol; Female; Glaucoma; Humans; Male; Middle Aged; Propanolamines | 1980 |
[Effect of topical bupranolol on glaucoma eyes (author's transl)].
Topics: Administration, Topical; Bupranolol; Glaucoma; Humans; Ophthalmic Solutions; Propanolamines | 1981 |
[Cytotoxic effects of antiglaucoma agents on cultured human conjunctival cells (author's transl)].
Topics: Benzalkonium Compounds; Bupranolol; Cell Survival; Conjunctiva; Epinephrine; Glaucoma; Humans; In Vi | 1981 |
[The immediate effect of beta-isoket on the internal ocular pressure in patients with chronic simple glaucoma (author's transl)].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Bupranolol; Chronic Disease; Drug Combinations; Drug Evalu | 1975 |
[Bupranolol eye-drops (Ophtorenin) in long-term therapy of glaucoma (author's transl)].
Topics: Acetazolamide; Adult; Aged; Bupranolol; Clonidine; Drug Combinations; Drug Tolerance; Female; Glauco | 1979 |
[Lowering of intraocular pressure by aqueous solution of bupranolol in chronic uncomplicated glaucoma simplex (author's transl)].
Topics: Aged; Bupranolol; Chronic Disease; Dose-Response Relationship, Drug; Female; Glaucoma; Humans; Intra | 1979 |
[Improvement of the drainage of the aqueous humor in chronic glaucoma simplex after administration of bupranolol and piloeserine].
Topics: Aqueous Humor; Bupranolol; Glaucoma; Humans; Intraocular Pressure; Physostigmine; Propanolamines | 1979 |
[The effects of oral bupranolol on intraocular pressure of primary open-angle glaucoma (author's transl)].
Topics: Administration, Oral; Adolescent; Adult; Aged; Bupranolol; Female; Glaucoma; Humans; Intraocular Pre | 1979 |
[Effect of a .2 percent acqueous bupranolol solution in chronic glaucoma with open iridocorneal angle].
Topics: Bupranolol; Glaucoma; Humans; Intraocular Pressure; Propanolamines | 1979 |
[Studies of bupranolol therapy for glaucoma. 2. Dose response and comparing to pilocarpine on intraocular pressure (author's transl)].
Topics: Adult; Bupranolol; Dose-Response Relationship, Drug; Glaucoma; Humans; Intraocular Pressure; Male; P | 1979 |
Effects of topically applied bupranolol on the intraocular pressure. Effects on the untreated eye.
Topics: Absorption; Administration, Intranasal; Administration, Topical; Adult; Bupranolol; Glaucoma; Humans | 1979 |